Senate Bill 4249
116th Congress(2019-2020)
A bill to ensure the protection of human genetic information collected as a result of diagnostic testing for COVID-19.
Introduced
Introduced in Senate on Jul 21, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4249
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
This bill prohibits the use of genetic material collected as a result of a COVID-19 (i.e., coronavirus disease 2019) test for any other purpose without the written, informed consent of the individual being tested.
A person who violates this prohibition is subject to a civil monetary penalty of not more than $100 for each violation.
July 21, 2020
Sort by most recent
07/21/2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
07/21/2020
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:45:38 PM